AARP (2021)

A small study has found that the experimental drug donanemab may slow cognitive decline in Alzheimer's patients. It joins others that show promise.

Comments

No comments yet. Be the first to comment!

Related Chunks

Related chunks with this resource

This Article can be found in 1 chunk
A collection of resources about battling Alzheimer’s offers comprehensive insights into understanding, preventing, and managing this complex neurological disease. The materials encompass the latest research on Alzheimer's pathology, effective caregiving strategies, and innovative therapeutic approaches. Key focus areas include early detection te...